CareLit · DOI-Nachweis · Zeitschrift für Gastroenterologie
Doxorubicin induces tumorigenicity and chemotherapy resistance of residual hepatocellular carcinoma cells in vitro
DOI 10.1055/s-0033-1360965
Bibliografische Angaben
Nachweis in CareLit
Autor:innenS Buschauer, C Hellerbrand
ZeitschriftZeitschrift für Gastroenterologie
Ausgabe01/2014
Jahrgang / SeitenNicht angegeben
Kernaussage aus der Literatur
Abstract-Vorschau
Transarterial chemoembolization (TACE) is a well-established therapeutic option in the treatment of hepatocellular carcinoma (HCC) with doxorubicin (DOX) as most widely used chemotherapeutic drug. Although patients undergoing TACE may have prolonged survival, local recurrence occurs in a significant number of cases. However, the tumorigenicity of residual HCC cells is not known and there exists no information regard…
Zitieren
Zitierempfehlung
S Buschauer, C Hellerbrand (2014) Doxorubicin induces tumorigenicity and chemotherapy resistance of residual hepatocellular carcinoma cells in vitro. Zeitschrift für Gastroenterologie (01). https://doi.org/10.1055/s-0033-1360965
Mit CareLit weiterarbeiten